You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

NEOTRIZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Neotrizine, and when can generic versions of Neotrizine launch?

Neotrizine is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in NEOTRIZINE is trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine). Additional details are available on the trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NEOTRIZINE?
  • What are the global sales for NEOTRIZINE?
  • What is Average Wholesale Price for NEOTRIZINE?
Summary for NEOTRIZINE
Drug patent expirations by year for NEOTRIZINE

US Patents and Regulatory Information for NEOTRIZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly NEOTRIZINE trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 006317-012 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Lilly NEOTRIZINE trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) TABLET;ORAL 006317-011 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

NEOTRIZINE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Cetirizine Hydrochloride (Neotrizine)

Introduction to Cetirizine Hydrochloride

Cetirizine hydrochloride, often marketed under brands like Zyrtec and Aller-Tec, is a widely used second-generation antihistamine. It is effective in treating various allergic conditions, including allergic rhinitis, conjunctivitis, and urticaria.

Global Market Size and Growth

The global cetirizine hydrochloride market was valued at approximately USD 6.3 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 2.6% to reach USD 8.0 billion by 2034[1][4].

Key Drivers of Market Growth

Increasing Prevalence of Allergies

The rising incidence of allergic diseases such as eczema, allergic conjunctivitis, and allergic rhinitis is a primary driver of the cetirizine hydrochloride market. Environmental pollution, changing lifestyles, and dietary habits contribute significantly to this trend[1][4].

Advancements in Drug Formulations

Recent innovations in drug formulations, such as dissolvable tablets and liquid formulations tailored for children, as well as combination therapies, enhance treatment efficacy and patient compliance. These advancements are expected to boost market growth[4].

Accessibility and Regulatory Support

The availability of cetirizine hydrochloride over-the-counter (OTC) in many regions and supportive regulatory environments further contribute to the market's expansion. OTC availability increases accessibility, making the drug more convenient for consumers[1][4].

Regional Market Insights

North America

The North American market is expected to witness significant growth due to the high incidence of allergic rhinitis and urticaria. The financial burden of allergic disorders on the population in this region also drives market expansion[1].

Asia Pacific

The Asia Pacific region is anticipated to experience the fastest revenue growth. Factors such as an aging population, rising healthcare expenditure, and increasing allergy awareness in developing nations contribute to this growth[1][4].

Europe

The European market is expanding steadily, driven by an aging population and the rising prevalence of allergies among senior citizens[1].

Latin America and Middle East & Africa

Latin America is an emerging region with increased healthcare spending due to a growing middle class, which could propel the market for cetirizine hydrochloride. Similarly, the Middle East and Africa are expected to see growth driven by improving healthcare infrastructure and increasing awareness of allergy management[1].

Competitive Landscape

The introduction of generic versions of cetirizine hydrochloride has increased competition in the market, leading to lower prices and greater accessibility for a broader range of socioeconomic backgrounds. However, the threat of new medication development could potentially slow the growth rate of cetirizine hydrochloride[1].

Financial Performance and Projections

Revenue and Market Size

As mentioned, the global cetirizine hydrochloride market was valued at USD 6.3 billion in 2024 and is projected to reach USD 8.0 billion by 2034, growing at a CAGR of 2.6%[1].

Investment Opportunities

Investors can focus on research and development (R&D) for innovative formulations, expand into emerging markets with high growth potential, and develop patient-centric solutions that address diverse consumer needs. These strategies can help capitalize on the growing demand for effective allergy treatments[4].

Challenges and Limitations

Regulatory Constraints

Stringent laws and regulations are significant factors restricting the growth of the cetirizine hydrochloride market. Compliance with these regulations can be challenging and may impact the market's overall growth trajectory[1].

Threat of New Medications

The development of new medications could pose a threat to the market share of cetirizine hydrochloride. However, its established safety profile and effectiveness continue to make it a preferred choice among medical professionals[1].

Innovations and Future Trends

Digital Healthcare Integration

The integration of digital healthcare technologies is expected to shape the cetirizine hydrochloride market. Telemedicine, online prescription services, and digital health platforms can enhance patient access and compliance with allergy treatments[4].

Patient-Centric Solutions

Developing patient-centric solutions, such as personalized treatment plans and mobile health applications, can improve patient care outcomes and drive market growth. These solutions address the diverse needs of consumers and enhance the overall treatment experience[4].

Key Takeaways

  • The global cetirizine hydrochloride market is valued at USD 6.3 billion in 2024 and is projected to grow at a CAGR of 2.6% to reach USD 8.0 billion by 2034.
  • Rising prevalence of allergic diseases and advancements in drug formulations are key drivers of market growth.
  • The Asia Pacific region is expected to witness the fastest revenue growth due to rising urbanization and healthcare expenditure.
  • Regulatory constraints and the threat of new medications are significant challenges.
  • Investment opportunities lie in R&D for innovative formulations and expansion into emerging markets.

FAQs

What is the current market size of cetirizine hydrochloride?

The global cetirizine hydrochloride market was valued at approximately USD 6.3 billion in 2024[1].

What is the projected growth rate of the cetirizine hydrochloride market?

The market is projected to grow at a CAGR of 2.6% to reach USD 8.0 billion by 2034[1].

What are the key drivers of the cetirizine hydrochloride market?

Key drivers include the increasing prevalence of allergic diseases, advancements in drug formulations, and supportive regulatory environments[1][4].

Which region is expected to witness the fastest revenue growth?

The Asia Pacific region is anticipated to experience the fastest revenue growth due to rising urbanization, increased healthcare expenditure, and growing allergy awareness[1][4].

What are the main challenges facing the cetirizine hydrochloride market?

The main challenges include stringent laws and regulations and the threat of new medication development[1].

Sources

  1. Prophecy Market Insights: Global Cetirizine Hydrochloride Market By Overview[1].
  2. Journal Of The History Of Medicine And Allied Sciences: Full text of "Journal Of The History Of Medicine And Allied Sciences(2)3"[2].
  3. UCB: UCB on Growth Path for a Decade Plus[3].
  4. Market Research Intellect: Cetirizine Hydrochloride Market Size And Projection[4].
  5. Krispin Sullivan: Naked at Noon - Krispin Sullivan[5].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.